VirTus develops new COVID-19 serology testing service

We are delighted to announce our new testing service for COVID-19

Click to find out more

Home

About us

Coronavirus

Our Services

Pre-clinical studies

Human Studies

Volunteers

Contact

VIRTUS RESPIRATORY RESEARCH

Accelerating respiratory clinical research
World leaders specialising in human challenge trials, Virtus provide a bespoke academic
approach to the design, supervision and analysis of respiratory clinical trials
Please note our last antibody test run will be on the 6th of December

Human Studies

Learn more

Human Studies

Pre Clinical Studies

Virtus’s range of in vitro and in vivo pre-clinical models

Learn more

Pre Clinical Studies

Our Team

Meet the Virtus team

Learn more

Our Team

News

Virtus team publication track record

Learn more

News

Our Vision

Virtus can assist in the development of new treatments for asthma and COPD

Learn more

Our Vision

COVID-19 Testing

COVID-19 Antibody testing

Learn more

COVID-19 Testing

Our team

Virtus’s Founders have worked together since 2001 in various academic and commercial settings.

Professor Sebastian Johnston

Director & Chief Medical Officer

Dr Michael Edwards

Managing & Scientific Director

Meet the full team

COVID-19 ANTIBODY TESTING

We are delighted to announce the launch of the first publicly available Covid-19 antibody test specifically for the Omicron variant.

FIND OUT MORE

Get in touch

Want to find out more how we can help you develop the next block-buster medicine in asthma or COPD? Get in touch.

Our clients

We partner with a range of clients from large pharmaceutical companies to biotechs to assist them in the development of new medicines for respiratory diseases.

View All

VIRTUS RESPIRATORY RESEARCH

Accelerating respiratory clinical research World leaders specialising in human challenge trials, Virtus provide a bespoke academic approach to the design, supervision and analysis of respiratory clinical trialsPlease note our last antibody test run will be on the 6th of December

Our team

Virtus’s Founders have worked together since 2001 in various academic and commercial settings.

COVID-19 ANTIBODY TESTING

We are delighted to announce the launch of the first publicly available Covid-19 antibody test specifically for the Omicron variant.

Get in touch

Want to find out more how we can help you develop the next block-buster medicine in asthma or COPD? Get in touch.

Our clients

We partner with a range of clients from large pharmaceutical companies to biotechs to assist them in the development of new medicines for respiratory diseases.

Keep Updated With Our Progress

Keep up with the latest results, news and other headlines from Virtus Respiratory Research.

Accelerating respiratory clinical research
World leaders specialising in human challenge trials, Virtus provide a bespoke academic
approach to the design, supervision and analysis of respiratory clinical trials
Please note our last antibody test run will be on the 6th of December